Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | LLY | JNJ | ||
| Company | Novo Nordisk A/S ADR | Eli Lilly and Company | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 110.19 | 805.00 | 159.70 | ||
| High | 110.66 | 820.19 | 160.28 | ||
| Low | 109.44 | 803.68 | 158.07 | ||
| Last | 109.72 | 806.14 | 158.24 | ||
| Change | -2.22 | -12.79 | -1.89 | ||
| % Change | -1.98% | -1.56% | -1.18% | ||
| Volume | 6,215,000 | 3,918,100 | 4,644,000 | ||
| 20-Day Average Volume | 4,712,320 | 3,345,245 | 5,972,350 | ||
| Previous Close | 111.94 | 818.93 | 160.13 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 115.59 | 893.70 | 161.96 | ||
| 20-Day Raw Stochastic | 18.62% | 22.11% | 1.96% | ||
| 20-Day Relative Strength | 31.24% | 30.15% | 41.36% | ||
| Weighted Alpha | -3.17 | +23.64 | +5.90 | ||
| Today's Opinion | 88% Sell | 24% Sell | 24% Buy | ||
| Previous Opinion | 88% Sell | 8% Sell | 40% Buy | ||
| Last Month's Opinion | 72% Sell | 56% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.35% since 10/28/24 | -9.99% since 10/28/24 | -2.08% since 10/28/24 | ||
| Low | 107.24 on 10/30/24 | 769.00 on 10/30/24 | 158.07 on 11/04/24 | ||
| High | 113.76 on 10/30/24 | 907.98 on 10/29/24 | 162.17 on 10/29/24 | ||
| 1-Month | |||||
| %Chg | -4.69% since 10/04/24 | -9.13% since 10/04/24 | -1.28% since 10/04/24 | ||
| Low | 107.24 on 10/30/24 | 769.00 on 10/30/24 | 158.07 on 11/04/24 | ||
| High | 120.56 on 10/11/24 | 937.00 on 10/14/24 | 166.75 on 10/15/24 | ||
| 3-Month | |||||
| %Chg | -13.94% since 08/02/24 | +0.21% since 08/02/24 | -3.59% since 08/02/24 | ||
| Low | 107.24 on 10/30/24 | 747.55 on 08/05/24 | 156.44 on 08/13/24 | ||
| High | 139.74 on 08/30/24 | 972.53 on 08/22/24 | 168.85 on 09/04/24 | ||
| 6-Month | |||||
| %Chg | -10.83% since 05/03/24 | +9.68% since 05/03/24 | +6.01% since 05/03/24 | ||
| Low | 107.24 on 10/30/24 | 736.00 on 05/06/24 | 143.71 on 05/29/24 | ||
| High | 148.15 on 06/25/24 | 972.53 on 08/22/24 | 168.85 on 09/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 502,334,368 | 777,423,360 | 385,532,672 | ||
| Shares Outstanding, K | 4,487,532 | 949,316 | 2,407,623 | ||
| Annual Sales | 33,724,300,000 | 34,124,100,000 | 85,159,000,000 | ||
| Annual Net Income | 12,150,770,000 | 5,240,400,000 | 35,153,000,000 | ||
| Last Quarter Sales | 9,821,060,000 | 11,302,800,000 | 22,471,000,000 | ||
| Last Quarter Net Income | 2,893,220,000 | 2,967,000,000 | 2,694,000,000 | ||
| 60-Month Beta | 0.43 | 0.43 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.65 on 08/07/24 | 1.18 on 10/30/24 | 2.42 on 10/15/24 | ||
| Latest Earnings Date | 11/06/24 | 10/30/24 | 10/15/24 | ||
| Most Recent Dividend | 0.362 on 08/16/24 | 1.300 on 08/15/24 | 1.240 on 08/27/24 | ||
| Next Ex-Dividends Date | 08/16/24 | 11/15/24 | 11/26/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 38.34 | 81.59 | 15.61 | ||